Helen S. Mayberg

This MedLibrary.org supplementary page on Helen S. Mayberg is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Helen S. Mayberg was born in 1956 in California. She is an American neurologist. Dr. Mayberg is known in particular for her work delineating abnormal brain function in patients with major depression using functional neuroimaging. This work led to the first pilot study of deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with treatment-resistant depression.

Contents

Biography

She obtained her M.D. from the University of Southern California in 1981. She specialized in neurology, completing her residency training at Columbia University’s Neurological Institute in New York City from 1982 through 1985. She then completed a research fellowship at Johns Hopkins University’s PET facility from 1985 to 1987.[1] Dr. Helen S. Mayberg is a professor, Departments of Psychiatry and Behavioral Sciences and Neurology, Emory University School of Medicine, Atlanta, Georgia, USA. She is also affiliated with Rotman Research Institute at Baycrest Centre and the Departments of Psychiatry and Neurology, University of Toronto, Toronto, Ontario, Canada. [2]

Dr. Mayberg's work

Deep Brain Stimulation (DBS)

Deep brain stimulation (DBS) is one of a group of treatments involving surgical implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain. This surgical procedure is used to treat severe essential tremor and the tremor, rigidity and bradykinesia (slow movement) associated with Parkinson's disease, as well as dystonia and other conditions. In March 2005, the results of a Canadian study performed by doctors from the University of Toronto (including Dr. Mayberg) were published indicating that DBS of Brodmann area 25 may also alleviate symptoms in patients suffering from treatment-resistant clinical depression.[3]

Awards and nominations

  • NARSAD Mental Health Research Association - Distinguished Investigator Award Recipient (2002)

Disclosures

Her disclosed grant supports include: the Canadian Institutes for Health Research, the National Institutes of Health, and the National Alliance for Research in Schizophrenia and Depression. She has served as a consultant for Advanced Neuromodulation Systems on deep brain stimulation.

Recent publications

  • Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic [4]
  • Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial [5]
  • Defining the Neural Circuitry of Depression: Toward a New Nosology With Therapeutic Implications [6]

Notes and references

External links

Wikipedia content modification information:

  • This page was last modified on 30 July 2008, at 06:28.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Helen S. Mayberg".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.